"Antimicrobial Resistance is a problem driven by misuse and overuse of antimicrobial medicines, including antibiotics and antivirals, and results in critical medicines losing effectiveness to treat infections," said Thomas Joseph, Head, AMR Awareness, Advocacy and Campaigns, World Health Organization (WHO).
"AMR inflicts significant mortality, morbidity and economic loss in low- and middle-income countries, including India. Several countries in Asia and Africa have observed a worrying trend of increasing drug resistance, while progress towards AMR containment efforts remain scattered and fragmented," said Dr Kamini Walia who is the Convener and Co-Chairperson of Scientific Committee of Global AMR Media Alliance (GAMA) and a senior AMR scientist at the Indian Council of Medical Research (ICMR).
Agrees Thomas: "AMR is associated with 5 million deaths a year. Besides this, there is the huge burden of morbidity and healthcare expenditure that can affect severely household welfare. The World Bank estimates that Global GDP could fall by US$ 1 to US$ 3.4 trillion annually after 2030 due to AMR," he added. The World Bank estimates that an additional 24 million people would be forced into extreme poverty by 2030 if no action is taken on AMR today.
7th Edition of the Standard Treatment Guidelines
The 7th Edition of the "Standard Treatment Guidelines: A Comprehensive Resource for Informed Clinical Decision-Making", was developed by Delhi Society for Promotion of Rational Use of Drugs (DSPRUD) and launched at Lady Hardinge Medical College in Delhi, India. The guideline launch took place at the 7th Diagnostic Stewardship Programme to combat AMR.
These guidelines encompass over 350 priority diseases across 11 medical super-specialties, providing medical experts with invaluable insights into clinical manifestations, therapeutic advances, patient management, and patient education.
Dr Atul Kotwal, Executive Director, National Health Systems Resource Centre (NHSRC is a technical support institute with National Health Mission of Government of India) said that NHSRC and DSPRUD are partners in disseminating and implementing Standard Treatment Guidelines effectively in clinical practice.
Over the past two years, these joint initiatives (guidelines and diagnostic stewardship programmes) have engaged over 10,000 healthcare professionals from across India, demonstrating the demand for continuous professional development and adherence to standardized treatment protocols.
Next Page 1 | 2 | 3 | 4 | 5 | 6 | 7
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
